PRNewsWire
21 Oct 2026, 21:40 UTC · 2h ago
Impact · against what's priced in
Vanda Pharmaceuticals' announcement of its Q3 2026 earnings date is a routine administrative update. It provides no material change to the company's fundamental valuation or outlook.
Scored by the NIS engine · methodology.
What the story claims
1 claim · scored −1 bearish … +1 bullish · 1 new · 0 priced in
Vanda Pharmaceuticals will release its third quarter 2026 financial results on October 28, 2026, after the market closes.
Newannounced today, Oct 21
So whatThis sets the immediate volatility horizon for the stock for the week of October 26.
More positive than 47% of claims this week
Which stocks this story touches
Continue reading
5 related stories
Top 2 movers · tap to explore
Near neutral — 91% of ticker scores this week are stronger
The article is a routine announcement regarding the scheduling of third quarter financial results.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
55m ago
